However, application of wortmannin in breast cancer cells MCF-7 induced apoptosis with pronounced morphological and biochemical apoptotic properties, suggesting AKT as a potential target gene in breast cancer cell therapy [57]. This evidence concerns the gene AKT1 and breast cancer.